---
title: Cardiovascular & Metabolic Specialty Services CROs in United States
path: /services/cardiovascular-specialty-services/us
companies_count: 10
---

# Cardiovascular & Metabolic Specialty Services CROs in United States

10 published CROs match Cardiovascular & Metabolic Specialty Services in United States.

Locations in this set include United States, United Kingdom, India, China, Spain, and Australia.

Capabilities that show up most often in this set: Biologics (Monoclonal Antibodies), Biologics (Other), Cell Therapy, Gene Therapy, and Small Molecule.

## Matching companies

- [Emerald Clinical](/companies/emeraldclinical)
  - Global clinical research organization with 25+ years of expertise, headquartered in Singapore with operations across Asia-Pacific, EMEA, and the Americas. Specializes in renal, oncology, cardiovascular, and early-phase research with deep scientific leadership and proven operational excellence.
- [ICON plc](/companies/iconplc)
  - ICON is a global clinical research organization providing full-service drug development and clinical trial solutions across early phase through post-marketing, including clinical operations, bioanalytical labs, cardiac safety, medical imaging, and regulatory affairs.
- [Lotus Clinical Research](/companies/lotuscr)
  - Specialized CRO supporting clinical development in neuroscience and metabolic disease across all phases, with direct access to 20 wholly-owned US research sites and 400+ beds.
- [Medpace](/companies/medpace)
  - Full-service CRO with 30+ years of organic growth, offering integrated clinical development services across all phases with wholly-owned central labs, bioanalytical lab, imaging core lab, and Phase I unit.
- [NorthernBio](/companies/northernbiolab)
  - Michigan-based preclinical CRO specializing in targeted drug delivery, molecular biology, and bioanalysis with three GLP-compliant facilities supporting non-GLP and GLP safety assessment studies.
- [Pharmaron](/companies/pharmaron)
  - Premier life science CRO and CDMO offering integrated R&D and manufacturing across drug discovery, preclinical, clinical development, and commercialization for small molecules, biologics, and cell & gene therapies. 25,000+ employees across China, US, and UK.
- [Sofpromed](/companies/sofpromed)
  - Full-service CRO specializing in Phase I–IV clinical trials across oncology, cardiovascular, metabolic, CNS, dermatological, infectious, and respiratory diseases, with global trial management capabilities and expertise in rare tumor research.
- [Syneos Health](/companies/syneoshealth)
  - Global CRO with 26,000+ employees offering integrated clinical development, regulatory affairs, and commercialization services. Helped develop or commercialize 96% of FDA-approved oncology drugs and 93% of EMA-authorized oncology products in the last five years.
- [Syngene International](/companies/syngeneintl)
  - Innovation-led CRDMO offering integrated scientific services from early discovery through commercial manufacturing, with cGMP-compliant facilities, 5,200+ scientists, and a new 50,000-liter single-use bioreactor capacity in the U.S.
- [Veranex](/companies/quartesian)
  - Veranex is an Innovation CRO uniting design, preclinical, clinical, regulatory, and market-access expertise for medical devices and diagnostics. The company accelerates development from concept through commercialization with integrated cross-disciplinary teams across 15 international hubs.